Bulk Manufacturer of Controlled Substances Registration, 2579 [2019-01502]
Download as PDF
<![CDATA[
2579
Federal Register / Vol. 84, No. 26 / Thursday, February 7, 2019 / Notices
The DEA has considered the factors in
21 U.S.C. 823(a) and determined that
the registration of these registrants to
manufacture the applicable basic classes
of controlled substances is consistent
with the public interest and with United
States obligations under international
treaties, conventions, or protocols in
effect on May 1, 1971. The DEA
investigated each of the company’s
maintenance of effective controls
against diversion by inspecting and
testing each company’s physical
security systems, verifying each
company’s compliance with state and
local laws, and reviewing each
company’s background and history.
Therefore, pursuant to 21 U.S.C.
823(a), and in accordance with 21 CFR
1301.33, the DEA has granted a
registration as a bulk manufacturer to
the above listed companies.
Dated: December 21, 2018.
John J. Martin,
Assistant Administrator.
The registrant listed below
has applied for and been granted
registration by the Drug Enforcement
Administration (DEA) as a bulk
manufacturer of various classes of
schedule II controlled substances.
[FR Doc. 2019–01501 Filed 2–6–19; 8:45 am]
SUPPLEMENTARY INFORMATION:
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
SUMMARY:
The
company listed below applied to be
registered as a bulk manufacturer of
various basic classes of controlled
substances. Information on a previously
published notice is listed below. No
comments or objections were submitted
for the notice.
Bulk Manufacturer of Controlled
Substances Registration
ACTION:
Notice of registration.
Company
FR Docket
Published
Janssen Pharmaceuticals, Inc ..........................................................................................................................
83 FR 55205
November 2, 2018.
The DEA has considered the factors in
21 U.S.C. 823(a) and determined that
the registration of this registrant to
manufacture the applicable basic classes
of controlled substances is consistent
with the public interest and with United
States obligations under international
treaties, conventions, or protocols in
effect on May 1, 1971. The DEA
investigated the company’s maintenance
of effective controls against diversion by
inspecting and testing the company’s
physical security systems, verifying the
company’s compliance with state and
local laws, and reviewing the company’s
background and history.
Therefore, pursuant to 21 U.S.C.
823(a), and in accordance with 21 CFR
1301.33, the DEA has granted a
registration as a bulk manufacturer to
the above listed company.
Dated: January 7, 2019.
John J. Martin,
Assistant Administrator.
[FR Doc. 2019–01502 Filed 2–6–19; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Bulk Manufacturer of Controlled
Substances Application: Kinetochem,
LLC
ACTION:
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before April 8, 2019.
Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152.
ADDRESSES:
The
Attorney General has delegated his
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Assistant
Administrator of the DEA Diversion
Control Division (‘‘Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR
1301.33(a), this is notice that on August
17, 2018, Kinetochem, LLC., 111 W
Cooperative Way, Ste. 310–B,
Georgetown, Texas 78626 applied to be
registered as a bulk manufacturer for the
basic classes of controlled substances:
SUPPLEMENTARY INFORMATION:
Controlled
substance
DATES:
VerDate Sep<11>2014
17:23 Feb 06, 2019
Jkt 247001
Marihuana .................
PO 00000
Frm 00093
Fmt 4703
Drug
code
7360
Sfmt 4703
Schedule
I
Controlled
substance
Tetrahydrocannabinols.
Drug
code
7370
Schedule
I
The company plans to manufacture
drug codes 7360 (marihuana) and 7370
(tetrahydrocannabinols), in bulk for
distribution and sale to its customers.
The company plans to synthetically
manufacture these drugs. No other
activities for these drug codes are
authorized for this registration.
Dated: December 21, 2018.
John J. Martin,
Assistant Administrator.
[FR Doc. 2019–01509 Filed 2–6–19; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Bulk Manufacturer of Controlled
Substances Application: Johnson
Matthey Pharmaceutical Materials, Inc.
ACTION:
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before April 8, 2019.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
DATES:
E:\FR\FM\07FEN1.SGM
07FEN1
]]>Agencies
[Federal Register Volume 84, Number 26 (Thursday, February 7, 2019)]
[Notices]
[Page 2579]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-01502]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Bulk Manufacturer of Controlled Substances Registration
ACTION: Notice of registration.
-----------------------------------------------------------------------
SUMMARY: The registrant listed below has applied for and been granted
registration by the Drug Enforcement Administration (DEA) as a bulk
manufacturer of various classes of schedule II controlled substances.
SUPPLEMENTARY INFORMATION: The company listed below applied to be
registered as a bulk manufacturer of various basic classes of
controlled substances. Information on a previously published notice is
listed below. No comments or objections were submitted for the notice.
------------------------------------------------------------------------
Company FR Docket Published
------------------------------------------------------------------------
Janssen Pharmaceuticals, Inc 83 FR 55205 November 2, 2018.
------------------------------------------------------------------------
The DEA has considered the factors in 21 U.S.C. 823(a) and
determined that the registration of this registrant to manufacture the
applicable basic classes of controlled substances is consistent with
the public interest and with United States obligations under
international treaties, conventions, or protocols in effect on May 1,
1971. The DEA investigated the company's maintenance of effective
controls against diversion by inspecting and testing the company's
physical security systems, verifying the company's compliance with
state and local laws, and reviewing the company's background and
history.
Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21
CFR 1301.33, the DEA has granted a registration as a bulk manufacturer
to the above listed company.
Dated: January 7, 2019.
John J. Martin,
Assistant Administrator.
[FR Doc. 2019-01502 Filed 2-6-19; 8:45 am]
BILLING CODE 4410-09-P
